FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$3.06Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $141,685,344.00
EPSttm : -2.98
4D Molecular Therapeutics, Inc.
$3.06
5.15%$0.15Float Short %
12.76
Margin Of Safety %
Put/Call OI Ratio
0.21
EPS Next Q Diff
0.01
EPS Last/This Y
-0.59
EPS This/Next Y
-0.4
Price
3.06
Target Price
32.55
Analyst Recom
1.75
Performance Q
-34.62
Relative Volume
0.45
Beta
2.81
Ticker: FDMT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | FDMT | 3.93 | 0.17 | 0.32 | 5153 |
| 2025-03-24 | FDMT | 3.94 | 0.14 | 0.73 | 5015 |
| 2025-03-25 | FDMT | 3.69 | 0.15 | 0.01 | 5150 |
| 2025-03-26 | FDMT | 3.6 | 0.15 | 0.05 | 5280 |
| 2025-03-27 | FDMT | 3.55 | 0.14 | 0.33 | 5295 |
| 2025-03-28 | FDMT | 3.63 | 0.13 | 2.10 | 5440 |
| 2025-03-31 | FDMT | 3.22 | 0.13 | 1.22 | 5450 |
| 2025-04-01 | FDMT | 2.98 | 0.12 | 0.16 | 5380 |
| 2025-04-02 | FDMT | 3.28 | 0.11 | 0.33 | 5733 |
| 2025-04-03 | FDMT | 2.88 | 0.11 | 0.60 | 5736 |
| 2025-04-04 | FDMT | 2.78 | 0.10 | 0.49 | 5693 |
| 2025-04-07 | FDMT | 2.64 | 0.10 | 2.82 | 5803 |
| 2025-04-08 | FDMT | 2.51 | 0.10 | 1.00 | 5832 |
| 2025-04-09 | FDMT | 2.76 | 0.10 | 0.03 | 5833 |
| 2025-04-10 | FDMT | 2.58 | 0.10 | 0.33 | 5893 |
| 2025-04-11 | FDMT | 2.62 | 0.10 | 1.35 | 5897 |
| 2025-04-14 | FDMT | 2.77 | 0.10 | 0.02 | 5916 |
| 2025-04-15 | FDMT | 3.1 | 0.10 | 0.01 | 5964 |
| 2025-04-16 | FDMT | 2.91 | 0.10 | 17.33 | 6110 |
| 2025-04-17 | FDMT | 3.05 | 0.21 | 0.19 | 6780 |
| 2025-04-18 | FDMT | 3.06 | 0.21 | 0.16 | 6780 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | FDMT | 3.92 | -30.4 | - | -3.57 |
| 2025-03-24 | FDMT | 3.93 | -30.4 | - | -3.57 |
| 2025-03-25 | FDMT | 3.69 | -30.4 | - | -3.57 |
| 2025-03-26 | FDMT | 3.61 | -30.4 | - | -3.57 |
| 2025-03-27 | FDMT | 3.55 | -30.4 | - | -3.57 |
| 2025-03-28 | FDMT | 3.63 | -30.4 | - | -3.57 |
| 2025-03-31 | FDMT | 3.23 | -30.4 | - | -3.57 |
| 2025-04-01 | FDMT | 2.99 | -30.4 | - | -3.57 |
| 2025-04-02 | FDMT | 3.28 | -30.4 | - | -3.57 |
| 2025-04-03 | FDMT | 2.88 | -30.4 | - | -3.57 |
| 2025-04-04 | FDMT | 2.77 | -30.4 | - | -3.57 |
| 2025-04-07 | FDMT | 2.64 | -30.4 | - | -3.57 |
| 2025-04-08 | FDMT | 2.51 | -30.4 | - | -3.57 |
| 2025-04-09 | FDMT | 2.75 | -30.4 | - | -3.57 |
| 2025-04-10 | FDMT | 2.59 | -30.4 | - | -3.57 |
| 2025-04-11 | FDMT | 2.63 | -30.4 | - | -3.57 |
| 2025-04-14 | FDMT | 2.78 | -30.4 | - | -3.57 |
| 2025-04-15 | FDMT | 3.10 | -30.4 | - | -3.57 |
| 2025-04-16 | FDMT | 2.91 | -30.4 | - | -3.57 |
| 2025-04-17 | FDMT | 3.06 | -30.4 | - | -3.57 |
| 2025-04-18 | FDMT | 3.06 | -30.4 | - | -3.57 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | FDMT | 0.00 | -23.77 | 13.22 |
| 2025-03-24 | FDMT | 0.00 | -23.74 | 13.22 |
| 2025-03-25 | FDMT | 0.00 | -23.74 | 13.22 |
| 2025-03-26 | FDMT | 0.00 | -23.74 | 12.69 |
| 2025-03-27 | FDMT | 0.00 | -23.74 | 12.69 |
| 2025-03-28 | FDMT | 0.00 | -23.74 | 12.69 |
| 2025-03-31 | FDMT | 0.00 | -23.77 | 12.69 |
| 2025-04-01 | FDMT | 0.00 | -23.77 | 12.69 |
| 2025-04-02 | FDMT | 0.00 | -23.77 | 12.69 |
| 2025-04-03 | FDMT | 0.00 | -23.77 | 12.69 |
| 2025-04-04 | FDMT | 0.00 | -23.77 | 12.69 |
| 2025-04-07 | FDMT | 0.00 | -23.65 | 12.69 |
| 2025-04-08 | FDMT | 0.00 | -23.65 | 12.69 |
| 2025-04-09 | FDMT | 0.00 | -23.65 | 12.69 |
| 2025-04-10 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-11 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-14 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-15 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-16 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-17 | FDMT | 0.00 | -23.65 | 12.76 |
| 2025-04-18 | FDMT | 0.00 | -23.65 | 12.76 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.9
Avg. EPS Est. Current Quarter
-0.86
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
Institutional Transactions
-23.65
Beta
2.81
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
26
Sentiment Score
67
Actual DrawDown %
94.5
Max Drawdown 5-Year %
Target Price
32.55
P/E
Forward P/E
PEG
P/S
3542.25
P/B
0.27
P/Free Cash Flow
EPS
-3.16
Average EPS Est. Cur. Y
-3.57
EPS Next Y. (Est.)
-3.97
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-434778.38
Relative Volume
0.45
Return on Equity vs Sector %
-51.5
Return on Equity vs Industry %
-38.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading